Oxprenolol 40mg tablets

Țară: Regatul Unit

Limbă: engleză

Sursă: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredient activ:

Oxprenolol hydrochloride

Disponibil de la:

Advanz Pharma

Codul ATC:

C07AA02

INN (nume internaţional):

Oxprenolol hydrochloride

Dozare:

40mg

Forma farmaceutică:

Oral tablet

Calea de administrare:

Oral

Clasă:

No Controlled Drug Status

Tip de prescriptie medicala:

Valid as a prescribable product

Rezumat produs:

BNF: 02040000

Caracteristicilor produsului

OBJECT 1
OXPRENOLOL 40 MG TABLETS
Summary of Product Characteristics Updated 08-Feb-2017 | ADVANZ Pharma
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Trasicor 40 mg Tablets.
Oxprenolol 40 mg Tablets.
2. Qualitative and quantitative composition
Each tablet contains 40 mg of oxprenolol hydrochloride.
Excipients with known effect:
Sucrose powder
(111.6 mg/tablet)
Wheat starch
(53 mg/tablet)
For the full list of excipients, see section 6.1
3. Pharmaceutical form
Film-coated tablets.
White round, biconvex, film-coated tablets with bevelled edges
impressed OXP 40 and no marking on the
other.
4. Clinical particulars
4.1 Therapeutic indications
Trasicor Tablets are indicated in adults for the treatment of:
Angina Pectoris: For long-term prophylactic use (if necessary nitrates
should be employed for alleviating
acute attacks).
Hypertension: As monotherapy or for use in combination with other
antihypertensives, e.g. with a
diuretic, peripheral vasodilator, calcium channel block